Liquid Biopsy Market by Cancer Type, by Sample Type, by Diagnostic Approach, By End Users and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)
According to the report Liquid Biopsy Market, published by Market Data Forecast, the Global market is projected to reach USD 2.18 billion by 2022, at a CAGR of 24.3% from 2017 to 2022.
Liquid Biopsy, also referred as fluid biopsy or fluid phase biopsy, is a method of analysis of a non solid biological tissue, predominantly blood. Similar to normal biopsy this method is used for diagnostic and monitory purposes to detect diseases like cancer.
This method is non invasive, thereby it can be performed frequently to track tumors and mutations.
Get a comprehensive overview of the Liquid Biopsy Market: www.marketdataforecast.com/market-…iopsy-market-950/
Liquid Biopsy Market: Drivers & Restraints
Factors fuelling the growth of market are high tolerance due to minimally invasive procedure and high patient convenience. This method is replacing tissue biopsy in some cancer diagnosis procedures like lung cancer where tissue biopsy is not feasible.
On the other hand, expensive processing techniques, high research costs involved and requirement of frequent clinical trials are the factors restricting the growth of market.
Get accurate market forecast and analysis on the Liquid Biopsy Market. Request a sample to stay up-to-date on the main trends affecting this market: www.marketdataforecast.com/market-…50/request-sample
Liquid Biopsy Market: Segmentation
By Cancer Type
By Sample Type
By Diagnostic Approach
By End Users
• North America
• Latin America
• Middle East & Africa
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at www.marketdataforecast.com/market-…/customize-report
Liquid Biopsy Market: Overview
Based on Cancer Type, Lung Cancer is expected to occupy the highest share in the market due to increasing prevalence of lung cancer caused by smoking. Based on End User, Cancer institutes are the largest segment due to extensive use of liquid biopsy in identification of cancer and increasing prevalence of cancers.
Regionally, North America dominated the Liquid Biopsy market due to the presence of key players and increasing activities promoting the diagnosis of cancer by both, government as well as NGOs. Asia Pacific is expected to grow the fastest due to increasing adoption rate and increasing government activities to develop the healthcare infrastructure.
Liquid Biopsy Market: Key Players
The key players dominating the liquid biopsy market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natera, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information:Make an Inquiry about this report HERE!